ライフサイエンスコーパス: small cell carcinoma

1 found in tumor samples of patients with non-small cell carcinoma.

2 CYP2E1 polymorphisms were also suggested for small cell carcinoma.

3 opy 2 days later and was diagnosed as having small cell carcinoma.

4 antibody binding type V were associated with small cell carcinoma.

5 nodes confirmed a poorly differentiated non-small-cell carcinoma.

6 plastic neurological autoimmunity related to small-cell carcinoma.

7 oximately 170 kDa antigen, in cerebellum and small-cell carcinoma.

8 s with advanced ovarian cancer and extensive small-cell carcinoma.

9 specificity for central airway squamous and small cell carcinomas.

10 enign typical carcinoids to highly malignant small-cell carcinomas.

11 with aggressive tumor characteristics in non-small-cell carcinomas.

12 ally the tumors in all six patients were non-small-cell carcinomas.

13 Eleven patients had confirmed small-cell carcinoma; 1 had imaging evidence of lung can

14 , followed by squamous cell carcinoma (19%), small cell carcinoma (19%), and others (12%).

15 is described in 16 patients: 11 with limited small-cell carcinoma, 2 with lung cancer revealed by ima

16 istinct neuronal nAChR subtypes expressed in small-cell carcinomas account for several lung cancer-re

17 Nine non-small cell carcinomas (adenocarcinoma, n = 4, including

18 In small cell carcinoma all stages should be treated with p

19 ions frequently deleted in lung cancer in 13 small cell carcinoma and 17 non-small cell lung carcinom

20 1.6; CI, 1.1-2.5), but not for subjects with small cell carcinomas and adenocarcinomas.

21 ations and X chromosome inactivation between small-cell carcinoma and coexisting urothelial carcinoma

22 itute an initial event in the development of small cell carcinomas, and 3) loss of heterozygosity at

23 e pancreas and ectopic peptide production in small-cell carcinoma, and to study PC2-dependent proteol

24 Incidence rates of adenocarcinoma, small-cell carcinoma, and undifferentiated tumours were

25 p130 is mutated in a human cell line of lung small cell carcinoma as well as in primary lung tumors.

26 because preoperative histologic diagnosis of small-cell carcinoma can dramatically alter the manageme

27 here were too few cases of squamous cell and small cell carcinoma in never smokers to eliminate the p

28 by additional neural autoantibody markers of small-cell carcinoma, including collapsin response-media

29 ally, although LCNEC is categorized as a non-small-cell carcinoma, it is more akin genetically and im

30 dition, we found ganglionic nAChR protein in small-cell carcinoma lines, identifying this cancer as a

31 one of which was initially misdiagnosed as a small-cell carcinoma, manifested a heterogeneous RB-posi

32 4,036), squamous cell carcinoma (n = 1,998), small cell carcinoma (n = 1,524), undifferentiated carci

33 ) and irregular margin (n = 5, 71%); for non-small cell carcinoma not otherwise specified (n = 5), so

34 Tumors previously classified as non-small-cell carcinoma, not otherwise specified, because o

35 arcinoma (SCC) and 135 of 279 (48%) with non-small cell carcinoma (NSCC) had positive aspirates (p =

36 reported to be autocrine growth factors for small cell carcinoma of the lung (SCCL).

37 us to human chromosome 3p gene(s) deleted in small cell carcinoma of the lung (SCLC).

38 The antibody was first associated with small cell carcinoma of the lung and is most often used

39 Similar to published studies of small cell carcinoma of the lung, collaborative efforts

40 isease treatments has been extrapolated from small cell carcinoma of the lung.

41 arcinoma and squamous cell carcinoma but not small cell carcinoma of the lung.

42 Small cell carcinoma of the ovary of hypercalcemic type

43 Small cell carcinoma of the ovary, hypercalcemic type (S

44 Small cell carcinoma of the ovary, hypercalcemic type (S

45 or understanding the origin and treatment of small cell carcinoma of the urinary bladder has become e

46 Small cell carcinoma of the urinary bladder is a rare an

47 The direction of investigation of small cell carcinoma of the urinary bladder using novel

48 The two small cell carcinomas of the lung showed little or no st

49 ibitors, generally DAF and CD59, whereas non-small cell carcinomas of the lung usually expressed CD59

50 that most carcinomas, with the exception of small cell carcinomas of the lung, do express one or mor

51 Stage is an important prognostic factor in small-cell carcinoma of the cervix, uterus, and ovary.

52 al and pathologic records for three cases of small-cell carcinoma of the esophagus contributed to the

53 chromosome 17p13 (TP53) in 20 patients with small-cell carcinoma of the urinary bladder and concurre

54 In most cases, small-cell carcinoma of the urinary bladder is admixed w

55 RECENT FINDINGS: Small-cell carcinomas of gynecologic sites are rare and

56 o correctly diagnose and treat patients with small-cell carcinomas of the cervix, ovary, uterus, vagi

57 Small-cell carcinomas of the esophagus can have similar

58 PURPOSE OF REVIEW: Small-cell carcinomas of the gynecologic tract are aggre

59 The small-cell carcinomas of the vagina and vulva need to be

60 A MEDLINE search was done, using the terms "small cell carcinoma" or "oat cell carcinoma" combined w

61 it was not detected in large cell carcinoma, small cell carcinoma, or atypical lung neuroendocrine ca

62 all tumor passages exhibit a neuroendocrine/small cell carcinoma phenotype-insensitivity to androgen

63 tumors from intrapulmonary metastases in non-small-cell carcinoma remains a clinical dilemma with sig

64 2589 squamous cell carcinomas (SQ), and 1418 small cell carcinomas (SC).

65 bronchogenic carcinoma, 50 of 81 (62%) with small cell carcinoma (SCC) and 135 of 279 (48%) with non

66 kers of neurological autoimmunity related to small-cell carcinoma, their frequency being ANNA-1 > col

67 with pure squamous cell, adenocarcinoma, or small cell carcinoma, there is clear evidence to alter t

68 Less differentiated tumors, diagnosed as small cell carcinomas, were also observed in two of the